IRF family of transcription factors as regulators of host defense

Annual Review of Immunology

Volumn 19, Issue , 2001, Pages 623-655

  Taniguchi, T ^a   Ogasawara, K ^a   Takaoka, A ^a   Tanaka, N ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cytokine; Interferon; Interferon regulatory factor; Oncogenesis; Transcriptional regulation

Indexed keywords

INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 4; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR 7; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CARCINOGENESIS; CELL FUNCTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNITY; CELL CYCLE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELIX-TURN-HELIX MOTIFS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNITY; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON REGULATORY FACTORS; INTERFERON-STIMULATED GENE FACTOR 3; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; INTERFERONS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MACROPHAGE ACTIVATION; NEOPLASMS; PHOSPHOPROTEINS; PROTEIN-TYROSINE KINASES; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRUS DISEASES;

EID: 0035061538     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.19.1.623     Document Type: Review

References (190)

1. Transcriptional activation: A complex puzzle with few easy pieces
2. Biochemistry of interferons and their actions
3. The interferon genes
4. Interferons and their actions
5. Interferons and other cytokines
6. Lymphocyte responses and cytokines
7. Interferon-gamma: Biology and role in pathogenesis
8. The IFNγ receptor: A paradigm for cytokine receptor signaling
9. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements
10. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes
11. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV
12. The growing family of interferon regulatory factors
13. Interferon regulatory factors: The next generation
14. The transcription factor IRF-1 and its family members in the regulation of host defense
15. Regulation of cytokine gene expression
16. Positive and negative control of human interferon-β gene expression
17. Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-β gene regulatory elements
18. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either
19. Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells
20. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: Role in growth inhibition
21. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system
22. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
23. Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated
24. Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1
25. + T cell mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signalling
26. Activation of IFN-β promoter element by IRF-1 requires a post-translational event in addition to IRF-1 synthesis
27. Interferon regulatory factor-2 is a transcriptional activator in muscle where it regulates expression of vascular cell adhesion molecule-1
28. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2
29. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes
30. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1
31. cIRF-3, a new member of the interferon regulatory factor (IRF) family that is rapidly and transiently induced by dsRNA
32. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency
33. Differential viral induction of distinct interferona genes by positive feedback through interferon regulatory factor-7
34. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7
35. Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/p300
36. Structural and functional analysis of interferon regulatory factor 3: Localization of the transactivation and autoinhibitory domains
37. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator
38. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE)
39. A novel interferon regulatory factor family transcription factor, IC-SAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes
40. An interferon regulatory factor-related gene (xIRF-6) is expressed in the posterior mesoderm during the early development of Xenopus laevis
41. An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes
42. Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes
43. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation
44. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family
45. Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA
46. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors
47. PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression
48. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins
49. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro
50. Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator
51. ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains
52. Proteins of transcription factor ISGF-3: One gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha
53. The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction
54. A transcription factor with SH2 and SH3 domains is directly activated by an interferon alpha-induced cytoplasmic protein tyrosine kinase(s)
55. ISGF3γ p48, a specificity switch for interferon activated transcription factors
56. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway
57. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription
58. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor
59. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2)
60. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors
61. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation
62. Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences
63. Interferons increase transcription of a major histocompatibility class I gene via a 5' interferon consensus sequence
64. Human β-interferon gene expression is regulated by an inducible enhancer element
65. Overlapping positive and negative regulatory domains of the human β-interferon gene
66. Jaks and Stats in signaling by the cytokine receptor superfamily
67. Cytokine signaling through nonreceptor protein tyrosine kinases
68. How cells respond to interferons
69. The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein
70. Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3
71. Activation of the transcription factor ISGF3 by interferon-γ
72. Cross talk between interferon-γ, and -α/β signaling components in caveolar membrane domains
73. Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses
74. Stat recruitment by tyrosine-phosphorylated cytokine receptors: An ordered reversible affinity-driven process
75. Phosphorylated interferon-alpha receptor 1 subunit (IFNαR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein
76. Functional subdomains of STAT2 required for preassociation with the α interferon receptor and for signaling
77. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways
78. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene
79. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: Implications for a gene network in the interferon system
80. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
81. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
82. A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity
83. Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-β gene expression
84. Phosphorylation of the oncogenic transcription factor interferon regulatory factor 2 (IRF2) in vitro and in vivo
85. The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene
86. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements
87. Recruitment of CBP/p300 by the IFNβ enhanceosome is required for synergistic activation of transcription
88. Cooperation of the tumor suppressors IRF-1 and p53 in response to DNA damage
89. The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain
90. Inducible processing of interferon regulatory factor-2
91. Characterization of TH3, an induction-specific protein interacting with the interferon β promoter
92. A truncated form of the IRF-2 transcription factor has the properties of a postinduction repressor of interferon-β gene expression
93. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-β gene
94. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation
95. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo
96. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes
97. p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide
98. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction
99. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3' enhancer activity
100. 2-4 enhancer
101. PU.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes
102. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
103. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1
104. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: Inhibiting function in vivo using fused dimers
105. Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1
106. The Ets protein Spi-B is expressed exclusively in B cells and T cells during development
107. Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52
108. Interferon consensus sequence binding protein and interferon regulatory factor-4/Pip form a complex that represses the expression of the interferon-stimulated gene-15 in macrophages
109. IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages
110. A 46-nucleotide promoter segment from an IFN-alpha gene renders an unrelated promoter inducible by virus
111. Delimitation and properties of DNA sequences required for the regulated expression of human interferon-β gene
112. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development
113. Mice devoid of interferon regulatory factor 1 (IRF-1)show normal expression of type I interferon genes
114. Regulation of IFN-α/β genes: Evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-α/β
115. Possible involvement of the transcription factor ISGF3 gamma in virus-induced expression of the IFN-β gene
116. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3)
117. Interferon-β is required for interferon-alpha production in mouse fibroblasts
118. Gene repression by coactivator repulsion
119. Involvement of the IRF-1 transcription factor in antiviral responses to interferons
120. Essential and non-redundant roles of p48 (ISGF3γ) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies
121. Biology of natural killer cells
122. Multistage regulation of Th1type immune responses by the transcription factor IRF-1
123. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo
124. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells
125. + T) cells, natural killer cells, and intestinal intraepithelial T cells
126. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells
127. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages
128. Role of interferon regulatory factor 1 in induction of nitric oxide synthase
129. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo
130. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis
131. Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon γ-dependent cyclooxygenase 2 expression
132. Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8 T cells in IRF-1 mice
133. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1
134. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo
135. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription
136. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene
137. + thymocytes
138. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function
139. The Janus protein tyrosine kinases in hematopoietic cytokine signaling
140. Negative regulation of cytokine signaling: STAT-induced STAT inhibitor
141. Negative regulation of cytokine signaling pathways
142. TGF-β signaling by Smad proteins
143. Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells
144. IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells
145. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction
146. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression
147. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1
148. The role of IFN regulatory factor-1 in synovitis and nitric oxide production
149. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2
150. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1
151. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bc1-2
152. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
153. IFN-β induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7
154. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1
155. The action of oncogenes in the cytoplasm and nucleus
156. Oncogenes, antioncogenes, and the molecular basis of multistep carcinogenesis
157. Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53
158. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression
159. Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras
160. Lysyl oxidase and rrg messenger RNA
161. Assignment of the human interferon regulatory factor-1 (IRF1) gene to chromosome 5q23-q31
162. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia
163. The 5q-anomaly
164. Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: Retention of IRF1 on the 5q-chromosome in some patients with the 5q-syndrome
165. Common deleted region on the long arm of chromosome 5 in esophageal carcinoma
166. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach
167. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer
168. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity
169. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation
170. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF
171. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder
172. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis
173. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias
174. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain
175. Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2
176. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
177. ICSAT overexpression is not sufficient to cause adult T-cell leukemia or multiple myeloma
178. Reversible tumorigenesis by MYC in hematopoietic lineages
179. Antiviral activity of tumor-suppressor pathways: Clues from molecular piracy by KSHV
180. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons
181. The interferon-inducible murine p48 (ISGF3γ) gene is regulated by protooncogene c-myc
182. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity
183. Activation of interferon regulatory factor 3 in response to DNA-damaging agents
184. Interferon regulatory factors: Growth control and histone gene regulation - It's not just interferon anymore
185. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription
186. The IRF-3 transcription factor mediates Sendal virus-induced apoptosis
187. Two domains of ISGFγ that mediate protein-DNA and protein-protein interactions during transcription factor assembly contribute to DNA-binding specificity